CENTRAL TRUST Co lifted its stake in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 162.2% in the 4th quarter, ...
New York, New York-- (Newsfile Corp. - February 5, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ: TMDX) for potential ...
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...
LOS ANGELES, CA / ACCESS Newswire / February 6, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
In truth, it appears that TransMedics fueled its growth by engaging in an anti-competitive scheme, including providing kickbacks to medical providers. The company further boosted growth by engaging in ...
TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant ...
SAN FRANCISCO, Jan. 31, 2025 (GLOBE NEWSWIRE) -- Shares of TransMedics, Group Inc. (NASDAQ: TMDX) suffered a sharp decline over the past two trading days following the release of a damaging report ...
NEW YORK CITY, NY / ACCESS Newswire / January 31, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ:TMDX) for potential ...
Shares of TransMedics, Group Inc. (NASDAQ: TMDX) suffered a sharp decline over the past two trading days following the release of a ...
This page features the latest news about the TransMedics stock. TMDX stock touches 52-week low at $68.8 amid market shifts TransMedics Group Inc (NASDAQ:TMDX) stock has reached a 52-week low ...
In 2024, momentum stocks led by NVIDIA have dominated the market's fastest-growing category, with companies like Supermicro, Pinduoduo, Coinbase, and Micron showing remarkable performance. Looking ...
1 Day TMDX -0.44% DJIA -1.26% S&P Mid Cap 400 -2.21% Health Care/Life Sciences 0.29% The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent ...